Literature DB >> 16439704

Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study.

Elisabeth C W van Straaten1, Franz Fazekas, Egill Rostrup, Philip Scheltens, Reinhold Schmidt, Leonardo Pantoni, Domenico Inzitari, Gunhild Waldemar, Timo Erkinjuntti, Riita Mäntylä, Lars-Olof Wahlund, Frederik Barkhof.   

Abstract

BACKGROUND AND
PURPOSE: White matter hyperintensities (WMH) are associated with decline in cognition, gait, mood, and urinary continence. Associations may depend on the method used for measuring WMH. We investigated the ability of different WMH scoring methods to detect differences in WMH load between groups with and without symptoms.
METHODS: We used data of 618 independently living elderly with WMH collected in the Leukoaraiosis And DISability (LADIS) study. Subjects with and without symptoms of depression, gait disturbances, urinary incontinence, and memory decline were compared with respect to WMH load measured qualitatively using 3 widely used visual rating scales (Fazekas, Scheltens, and Age-Related White Matter Changes scales) and quantitatively with a semiautomated volumetric technique and an automatic lesion count. Statistical significance between groups was assessed with the chi2 and Mann-Whitney tests. In addition, the punctate and confluent lesion type with comparable WMH volume were compared with respect to the clinical data using Student t test and chi2 test. Direct comparison of visual ratings with volumetry was done using curve fitting.
RESULTS: Visual and volumetric assessment detected differences in WMH between groups with respect to gait disturbances and age. WMH volume measurement was more sensitive than visual scores with respect to memory symptoms. Number of lesions nor lesion type correlated with any of the clinical data. For all rating scales, a clear but nonlinear relationship was established with WMH volume.
CONCLUSIONS: Visual rating scales display ceiling effects and poor discrimination of absolute lesion volumes. Consequently, they may be less sensitive in differentiating clinical groups.

Entities:  

Mesh:

Year:  2006        PMID: 16439704     DOI: 10.1161/01.STR.0000202585.26325.74

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  97 in total

1.  MRI signal hyperintensities and treatment remission of geriatric depression.

Authors:  Faith M Gunning-Dixon; Michael Walton; Janice Cheng; Jessica Acuna; Sibel Klimstra; Molly E Zimmerman; Adam M Brickman; Matthew J Hoptman; Robert C Young; George S Alexopoulos
Journal:  J Affect Disord       Date:  2010-05-07       Impact factor: 4.839

2.  MR imaging of brain volumes: evaluation of a fully automatic software.

Authors:  K Ambarki; A Wåhlin; R Birgander; A Eklund; J Malm
Journal:  AJNR Am J Neuroradiol       Date:  2010-11-04       Impact factor: 3.825

3.  Impact of White Matter Lesions on Depression in the Patients with Alzheimer's Disease.

Authors:  Jung Jae Lee; Eun Young Lee; Seok Bum Lee; Joon Hyuk Park; Tae Hui Kim; Hyun-Ghang Jeong; Jae Hyoung Kim; Ji Won Han; Ki Woong Kim
Journal:  Psychiatry Investig       Date:  2015-09-30       Impact factor: 2.505

Review 4.  The contribution of white matter lesions to Parkinson's disease motor and gait symptoms: a critical review of the literature.

Authors:  Branislav Veselý; Angelo Antonini; Ivan Rektor
Journal:  J Neural Transm (Vienna)       Date:  2015-10-19       Impact factor: 3.575

5.  Interaction between Obstructive Sleep Apnea and Shortened Telomere Length on Brain White Matter Abnormality.

Authors:  Kyung-Mee Choi; Robert J Thomas; Dai Wui Yoon; Seung Ku Lee; Inkyung Baik; Chol Shin
Journal:  Sleep       Date:  2016-09-01       Impact factor: 5.849

6.  An automated procedure for the assessment of white matter hyperintensities by multispectral (T1, T2, PD) MRI and an evaluation of its between-centre reproducibility based on two large community databases.

Authors:  Pauline Maillard; Nicolas Delcroix; Fabrice Crivello; Carole Dufouil; Sebastien Gicquel; Marc Joliot; Nathalie Tzourio-Mazoyer; Annick Alpérovitch; Christophe Tzourio; Bernard Mazoyer
Journal:  Neuroradiology       Date:  2007-10-16       Impact factor: 2.804

7.  Setting a gold standard for quantification of leukoaraiosis burden in patients with ischemic stroke: the Atherosclerosis Risk in Communities Study.

Authors:  Natalia S Rost; Saloomeh Sadaghiani; Alessandro Biffi; Kaitlin M Fitzpatrick; Lisa Cloonan; Jonathan Rosand; Dean K Shibata; Thomas H Mosley
Journal:  J Neurosci Methods       Date:  2014-01-15       Impact factor: 2.390

8.  Neuropathological basis of magnetic resonance images in aging and dementia.

Authors:  William J Jagust; Ling Zheng; Danielle J Harvey; Wendy J Mack; Harry V Vinters; Michael W Weiner; William G Ellis; Chris Zarow; Dan Mungas; Bruce R Reed; Joel H Kramer; Norbert Schuff; Charles DeCarli; Helena C Chui
Journal:  Ann Neurol       Date:  2008-01       Impact factor: 10.422

9.  Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia.

Authors:  Elisabeth C W van Straaten; Danielle Harvey; Philip Scheltens; Frederik Barkhof; Ronald C Petersen; Leon J Thal; Clifford R Jack; Charles DeCarli
Journal:  J Neurol       Date:  2008-09-25       Impact factor: 4.849

10.  Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort.

Authors:  Domenico Inzitari; Giovanni Pracucci; Anna Poggesi; Giovanna Carlucci; Frederik Barkhof; Hugues Chabriat; Timo Erkinjuntti; Franz Fazekas; José M Ferro; Michael Hennerici; Peter Langhorne; John O'Brien; Philip Scheltens; Marieke C Visser; Lars-Olof Wahlund; Gunhild Waldemar; Anders Wallin; Leonardo Pantoni
Journal:  BMJ       Date:  2009-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.